- Report
- July 2025
- 350 Pages
Global
From €4416EUR$4,949USD£3,894GBP
- Report
- June 2025
- 400 Pages
Global
From €4416EUR$4,949USD£3,894GBP
- Report
- June 2025
- 400 Pages
Global
From €4416EUR$4,949USD£3,894GBP
- Report
- June 2025
- 400 Pages
Global
From €4416EUR$4,949USD£3,894GBP
- Report
- June 2025
- 257 Pages
Global
From €4457EUR$4,995USD£3,930GBP
- Report
- April 2025
- 225 Pages
Global
From €4457EUR$4,995USD£3,930GBP
- Report
- April 2025
- 124 Pages
Global
From €3500EUR$4,202USD£3,194GBP
- Report
- June 2025
- 400 Pages
Global
From €4416EUR$4,949USD£3,894GBP
- Report
- October 2025
- 150 Pages
Global
From €3435EUR$3,850USD£3,029GBP
- Report
- September 2025
- 150 Pages
Global
From €3435EUR$3,850USD£3,029GBP
- Report
- September 2025
- 150 Pages
Global
From €3435EUR$3,850USD£3,029GBP
- Report
- September 2025
- 150 Pages
Global
From €3435EUR$3,850USD£3,029GBP
- Report
- August 2025
- 150 Pages
Global
From €2543EUR$2,850USD£2,242GBP
€3435EUR$3,850USD£3,029GBP
- Report
- May 2025
- 150 Pages
Global
From €3435EUR$3,850USD£3,029GBP
€4328EUR$4,850USD£3,816GBP
- Report
- June 2025
- 52 Pages
Global
From €6692EUR$7,500USD£5,901GBP
- Report
- December 2024
Global
From €6692EUR$7,500USD£5,901GBP
- Directory
- November 2025
Global
From €3524EUR$3,950USD£3,108GBP
- Newsletter
- November 2025
- 88 Pages
Global
€1176EUR$1,318USD£1,037GBP
- Report
- February 2025
- 135 Pages
Global
From €3678EUR$4,123USD£3,243GBP
€4328EUR$4,850USD£3,816GBP
- Report
- February 2025
- 130 Pages
Global
From €3678EUR$4,123USD£3,243GBP
€4328EUR$4,850USD£3,816GBP

The tumor market within the context of oncology is a rapidly growing sector of the healthcare industry. It is focused on the diagnosis, treatment, and prevention of cancer. This market includes a wide range of products and services, such as drugs, medical devices, diagnostics, and imaging technologies. It also includes services such as radiation therapy, chemotherapy, and immunotherapy.
The tumor market is driven by the increasing prevalence of cancer, advances in technology, and the development of new treatments. It is also driven by the increasing demand for personalized medicine and the need for better patient outcomes.
The tumor market is highly competitive, with many companies competing for market share. Some of the major players in the market include Roche, Novartis, Merck, AstraZeneca, Pfizer, and Bristol-Myers Squibb. Other companies in the market include AbbVie, Amgen, Celgene, Eli Lilly, and GlaxoSmithKline. Show Less Read more